Heron Therapeutics, INC. /DE/
SEC CIK 818033 · appa · last insider filing 2026-06-17
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Collard Craig A | Director · Chief Executive Officer | filed 2023 - 2026 |
| Johnson Craig A | Director | filed 2014 - 2026 |
| Christian Waage | Director | filed 2016 - 2026 |
| Kaseta Michael | Director | filed 2024 - 2026 |
| Dissanaike Sharmila | Director | filed 2021 - 2026 |
| Morgan Adam | Director | filed 2023 - 2026 |
| Cusack Thomas | Director | filed 2025 - 2026 |
| Rodriguez Susan | Director | filed 2021 - 2025 |
| Manhard Kimberly | Director · Executive VP, Drug Development | filed 2014 - 2023 |
| Poyhonen John | Director · President & CCO | filed 2014 - 2023 |
| Kotler Kevin | Director | filed 2023 - 2023 |
| Quart Barry D | Director · President & CEO | filed 2012 - 2023 |
| Davis Stephen | Director · Chief Operating Officer | filed 2010 - 2022 |
| Tang Kevin C | Director | filed 2007 - 2021 |
| Rosen Robert | Director · SVP & Chief Commercial Officer | filed 2012 - 2018 |
| Tang Capital Partners LP | Director | filed 2007 - 2018 |
| Tang Capital Management LLC | Director | filed 2007 - 2018 |
| Whelan John | Director · President, CEO and CFO | filed 2009 - 2013 |
| Goddard Paul | Director | filed 2006 - 2012 |
| Turnbull Greg | Director · President, CEO and Director | filed 2006 - 2012 |
| Zerbe Robert L MD | Director | filed 2006 - 2010 |
| Rosenblatt Toby | Director | filed 2006 - 2010 |
| Prentki Ronald J | Director · President & CEO | filed 2008 - 2010 |
| Taylor Arthur T | Director | filed 2006 - 2008 |
| Riepenhausen Peter | Director | filed 2006 - 2008 |
| Drury Stephen A | Director | filed 2006 - 2006 |
| Winger Dennis L | Director | filed 2006 - 2006 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Duarte Ira | EVP, Chief Financial Officer | filed 2023 - 2026 |
| Forbes William P | EVP, Chief Development Officer | filed 2023 - 2026 |
| Hensley Mark Earl | Chief Operating Officer | filed 2025 - 2026 |
| Peraza Lisa | VP, Chief Accounting Officer | filed 2020 - 2024 |
| Szekeres David Leslie | EVP, Chief Operating Officer | filed 2020 - 2023 |
| Hoffman Robert E. | CFO & SVP, Finance | filed 2017 - 2019 |
| Drazba Brian G. | VP, Finance & CFO | filed 2013 - 2016 |
| Marshall Paul | SVP, Technical Operations | filed 2013 - 2016 |
| Clendeninn Neil James | SVP & Chief Medical Officer | filed 2015 - 2015 |
| Gelder Mark S. MD | SVP & Chief Medical Officer | filed 2012 - 2014 |
| Adam Michael A | Chief Operating Officer | filed 2011 - 2013 |
| Barr John | Vice President of R&D | filed 2006 - 2011 |
| Retzios Anastassios D. | VP of Clinical Development | filed 2006 - 2008 |
| Whiteford Stephen | V.P., Finance & CFO | filed 2006 - 2006 |
| Oconnell Michael | Chief Executive Officer | filed 2006 - 2006 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.